.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Federal Trade Commission
Covington
Boehringer Ingelheim
UBS
Farmers Insurance
Mallinckrodt
McKinsey
Healthtrust
Julphar

Generated: September 25, 2017

DrugPatentWatch Database Preview

Ritodrine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for ritodrine hydrochloride and what is the scope of ritodrine hydrochloride patent protection?

Ritodrine hydrochloride
is the generic ingredient in three branded drugs marketed by Hospira, Astrazeneca, and Abraxis Pharm, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for ritodrine hydrochloride.

Summary for Generic Name: ritodrine hydrochloride

Tradenames:3
Patents:0
Applicants:3
NDAs:7
Drug Master File Entries: see list5
Bulk Api Vendors: see list45
Clinical Trials: see list2,283
Patent Applications: see list346
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:ritodrine hydrochloride at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca
YUTOPAR
ritodrine hydrochloride
TABLET;ORAL018555-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Abraxis Pharm
RITODRINE HYDROCHLORIDE
ritodrine hydrochloride
INJECTABLE;INJECTION071188-001Jul 23, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
RITODRINE HYDROCHLORIDE
ritodrine hydrochloride
INJECTABLE;INJECTION071619-001Feb 28, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
Astrazeneca
YUTOPAR
ritodrine hydrochloride
INJECTABLE;INJECTION018580-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Astrazeneca
YUTOPAR
ritodrine hydrochloride
INJECTABLE;INJECTION018580-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
RITODRINE HYDROCHLORIDE
ritodrine hydrochloride
INJECTABLE;INJECTION071618-001Feb 28, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
Abraxis Pharm
RITODRINE HYDROCHLORIDE
ritodrine hydrochloride
INJECTABLE;INJECTION071189-001Jul 23, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
ritodrine hydrochloride
INJECTABLE;INJECTION071438-001Jan 22, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: ritodrine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca
YUTOPAR
ritodrine hydrochloride
TABLET;ORAL018555-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Astrazeneca
YUTOPAR
ritodrine hydrochloride
INJECTABLE;INJECTION018580-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Astrazeneca
YUTOPAR
ritodrine hydrochloride
INJECTABLE;INJECTION018580-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Federal Trade Commission
Moodys
Cantor Fitzgerald
Colorcon
Fuji
Baxter
UBS
Chinese Patent Office
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot